Future Directions for the National Healthcare Quality and Disparities Reports

Table F-1: EPV-QIR Calculations for 18 NHQR Measures

Table F-1. EPV-QIR Calculations for 18 NHQR Measures

Mnemonic NHQR Measure Denominator Population Pop. VPI (QALYs) Pop. VCI (QALYs) Pop. Max VQI (QALYs)
NHQR_DMHTN Percent of adults with diagnosed diabetes with most recent blood pressure <140/80 mm/Hg 17,268,973 7,021,537 4,107,599 2,913,938
NHQR_DMCHOL Adults age 40 and over with diagnosed diabetes with total cholesterol <200 mg/dL 17,268,973 1,828,056 1,003,602 1,003,602 824,453
NHQR_DMFOOT Adults age 40+ with diagnosed diabetes who had their feet checked for sores or irritation in the calendar year 17,268,973 2,326,165 1,644,599 681,566
NHQR_DMHBA1C Percent of adults with diagnosed diabetes with HbA1c level >9.5% (poor control); <7.0 (optimal); <9.0 (minimally acceptable) 17,268,973 1,474,394 805,019 669,375
NHQR_HIVEVER People ages 15-44 who ever received an HIV test outside of blood donation 126,006,034 529,704 241,545 288,159
NHQR_PAP3YR Percent of women (age 18 and over) who report they had a Pap smear within the past 3 yrs 15,272,448 2,120,558 1,903,757 216,801
NHQR_DMEYE Adults age 40+ with diagnosed diabetes who received a dilated eye examination in the calendar year 17,268,973 414,132 247,237 166,895
NHQR_CRC50EVERCOLON Adults age 50 and over who ever received a colonoscopy, sigmoidoscopy, or proctoscopy 14,992,188 366,829 219,454 147,375
NHQR_BRCA2YRMAMM Percent of women (age 40+) who report they had a mammogram within the past 2 year 60,428,554 1,167,474 1,046,640 120,833
NHQR_CRCBIFOBT Adults age 50 and over who received a fecal occult blood test (FOBT) in the last 2 years 6,895,908 253,938 152,497 101,441
NHQR_CAPVACC65EVER Percent of individuals age 65+ who ever received a pneumococcal vaccination 38,869,716 161,291 92,420 68,871
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine silver sulfadiazine coated catheters (external coat)
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -27,809 27,809
NHQR_BSICVC
VQI represents QALYs that can be saved by using silver, platinum and carbon coated catheters
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -27,095 27,095
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine minocycline and rifampicin coated catheters
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -24,864 24,864
NHQR_BSICVC
VQI represents QALYs that can be saved by using chlorhexidine silver sulfadiazine coated catheters (internal + external coat)
Bloodstream infections (BSIs) per 1,000 central venous catheter (CVC) placements 140,000 0 -23,001 23,001
NHQR_AMIBB Percent of AMI patients administered beta blockers prescribed at discharge 682,699 123,172 109,623 13,549
NHQR_HFACE Percent of hospital patients with heart failure and left ventricular systolic dysfunction who were prescribed ACE inhibitor or ARB at discharge 295,101 64,976 55,359 9,616
NHQR_AMIACE Percent of AMI patients with LVSD prescribed ACE inhibitor at discharge 185,695 44,830 38,509 6,321

Return to Document

 

Page last reviewed October 2014
Page originally created September 2012
Internet Citation: Table F-1: EPV-QIR Calculations for 18 NHQR Measures. Content last reviewed October 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/iomqrdrreport/futureqrdrapftab1.html